000 | 01030 a2200289 4500 | ||
---|---|---|---|
005 | 20250513225057.0 | ||
264 | 0 | _c20010111 | |
008 | 200101s 0 0 eng d | ||
022 | _a1107-3756 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aArranz, M J | |
245 | 0 | 0 |
_aNeurotransmitter receptor variants and their influence on antipsychotic treatment (Review)). _h[electronic resource] |
260 |
_bInternational journal of molecular medicine _cJan 2001 |
||
300 |
_a27-30 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
650 | 0 | 4 | _aGenetic Variation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPolymorphism, Genetic |
650 | 0 | 4 |
_aPsychotic Disorders _xdrug therapy |
650 | 0 | 4 |
_aReceptors, Neurotransmitter _xgenetics |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aMancama, D | |
700 | 1 | _aKerwin, R W | |
773 | 0 |
_tInternational journal of molecular medicine _gvol. 7 _gno. 1 _gp. 27-30 |
|
999 |
_c11056779 _d11056779 |